630 related articles for article (PubMed ID: 22134793)
1. Pragmatic decisions over nonsteroidal antiinflammatory drug treatment in osteoarthritis--continuous versus intermittent.
Moore RA
J Rheumatol; 2011 Dec; 38(12):2501-3. PubMed ID: 22134793
[No Abstract] [Full Text] [Related]
2. Treatment of osteoarthritis with continuous versus intermittent celecoxib.
Strand V; Simon LS; Dougados M; Sands GH; Bhadra P; Breazna A; Immitt J
J Rheumatol; 2011 Dec; 38(12):2625-34. PubMed ID: 22045833
[TBL] [Abstract][Full Text] [Related]
3. A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip.
Luyten FP; Geusens P; Malaise M; De Clerck L; Westhovens R; Raeman F; Vander Mijnsbrugge D; Mathy L; Hauzeur JP; De Keyser F; Van den Bosch F
Ann Rheum Dis; 2007 Jan; 66(1):99-106. PubMed ID: 16815864
[TBL] [Abstract][Full Text] [Related]
4. Tramadol hydrochloride extended-release once-daily in the treatment of osteoarthritis of the knee and/or hip: a double-blind, randomized, dose-ranging trial.
DeLemos BP; Xiang J; Benson C; Gana TJ; Pascual ML; Rosanna R; Fleming B
Am J Ther; 2011 May; 18(3):216-26. PubMed ID: 20215961
[TBL] [Abstract][Full Text] [Related]
5. Early response to COX-2 inhibitors as a predictor of overall response in osteoarthritis: pooled results from two identical trials comparing etoricoxib, celecoxib and placebo.
Bingham CO; Smugar SS; Wang H; Tershakovec AM
Rheumatology (Oxford); 2009 Sep; 48(9):1122-7. PubMed ID: 19589894
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies.
Bingham CO; Sebba AI; Rubin BR; Ruoff GE; Kremer J; Bird S; Smugar SS; Fitzgerald BJ; O'Brien K; Tershakovec AM
Rheumatology (Oxford); 2007 Mar; 46(3):496-507. PubMed ID: 16936327
[TBL] [Abstract][Full Text] [Related]
7. First-dose analgesic effect of the cyclo-oxygenase-2 selective inhibitor lumiracoxib in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled comparison with celecoxib [NCT00267215].
Wittenberg RH; Schell E; Krehan G; Maeumbaed R; Runge H; Schlüter P; Fashola TO; Thurston HJ; Burger KJ; Trechsel U
Arthritis Res Ther; 2006; 8(2):R35. PubMed ID: 16469112
[TBL] [Abstract][Full Text] [Related]
8. Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a prospective randomized 13-week study versus placebo and celecoxib.
Fleischmann R; Sheldon E; Maldonado-Cocco J; Dutta D; Yu S; Sloan VS
Clin Rheumatol; 2006 Feb; 25(1):42-53. PubMed ID: 16132165
[TBL] [Abstract][Full Text] [Related]
9. Use and misuse of the p-value.
Lesaffre E
Bull NYU Hosp Jt Dis; 2008; 66(2):146-9. PubMed ID: 18537787
[TBL] [Abstract][Full Text] [Related]
10. Antiinflammatory and analgesic efficacy of COX-2 specific inhibition: from investigational trials to clinical experience.
Bensen WG
J Rheumatol Suppl; 2000 Oct; 60():17-24. PubMed ID: 11032098
[TBL] [Abstract][Full Text] [Related]
11. A prospective, randomized, double-blind, multicenter comparative study on the safety and efficacy of Celecoxib and GCSB-5, dried extracts of six herbs, for the treatment of osteoarthritis of knee joint.
Park YG; Ha CW; Han CD; Bin SI; Kim HC; Jung YB; Lim HC
J Ethnopharmacol; 2013 Oct; 149(3):816-24. PubMed ID: 23954277
[TBL] [Abstract][Full Text] [Related]
12. Responder analysis and correlation of outcome measures: pooled results from two identical studies comparing etoricoxib, celecoxib, and placebo in osteoarthritis.
Bingham CO; Bird SR; Smugar SS; Xu X; Tershakovec AM
Osteoarthritis Cartilage; 2008 Nov; 16(11):1289-93. PubMed ID: 18514551
[TBL] [Abstract][Full Text] [Related]
13. A randomized, multicentre, double-blind, parallel-group study to assess the adverse event-related discontinuation rate with celecoxib and diclofenac in elderly patients with osteoarthritis.
Dahlberg LE; Holme I; Høye K; Ringertz B
Scand J Rheumatol; 2009; 38(2):133-43. PubMed ID: 19165648
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of intra-articular injection of celecoxib in a rabbit model of osteoarthritis.
Jiang D; Zou J; Huang L; Shi Q; Zhu X; Wang G; Yang H
Int J Mol Sci; 2010 Oct; 11(10):4106-13. PubMed ID: 21152323
[TBL] [Abstract][Full Text] [Related]
15. An open-label pilot study evaluating by magnetic resonance imaging the potential for a disease-modifying effect of celecoxib compared to a modelized historical control cohort in the treatment of knee osteoarthritis.
Raynauld JP; Martel-Pelletier J; Beaulieu A; Bessette L; Morin F; Choquette D; Haraoui B; Abram F; Pelletier JP
Semin Arthritis Rheum; 2010 Dec; 40(3):185-92. PubMed ID: 20132966
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of lumiracoxib in the treatment of osteoarthritis of the knee: a 13-week, randomized, double-blind comparison with celecoxib and placebo.
Sheldon E; Beaulieu A; Paster Z; Dutta D; Yu S; Sloan VS
Clin Ther; 2005 Jan; 27(1):64-77. PubMed ID: 15763607
[TBL] [Abstract][Full Text] [Related]
17. Cost-utility analysis and economic burden of knee osteoarthritis treatment: the analysis from the real clinical practice.
Turajane T; Chaweevanakorn U; Sungkhun P; Larbphiboonpong V; Wongbunnak R
J Med Assoc Thai; 2012 Oct; 95 Suppl 10():S98-104. PubMed ID: 23451446
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults.
Kivitz A; Fairfax M; Sheldon EA; Xiang Q; Jones BA; Gammaitoni AR; Gould EM
Clin Ther; 2008 Dec; 30(12):2366-77. PubMed ID: 19167595
[TBL] [Abstract][Full Text] [Related]
19. Nonsteroidal antiinflammatory drugs and prostaglandin E(2) modulate the synthesis of osteoprotegerin and RANKL in the cartilage of patients with severe knee osteoarthritis.
Moreno-Rubio J; Herrero-Beaumont G; Tardio L; Alvarez-Soria MA; Largo R
Arthritis Rheum; 2010 Feb; 62(2):478-88. PubMed ID: 20112374
[TBL] [Abstract][Full Text] [Related]
20. Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis.
Pincus T; Koch G; Lei H; Mangal B; Sokka T; Moskowitz R; Wolfe F; Gibofsky A; Simon L; Zlotnick S; Fort JG
Ann Rheum Dis; 2004 Aug; 63(8):931-9. PubMed ID: 15082468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
